With a smart dual-modality design, Aerolase Reverse™ empowers practitioners to treat multiple skin concerns in one efficient, comprehensive treatment.
In the evolving landscape of energy-based dermatology, precision and versatility are no longer optional – they’re expected. At the intersection of evidence-based medicine and device innovation stands Aerolase Reverse™, a next-generation laser protocol that integrates two proven wavelengths for comprehensive dermatological treatment, all in a single session.
More than a technological upgrade, Aerolase Reverse™ represents a strategic evolution in how clinicians can address multiple benign skin conditions — with a focus on safety, clinical scope and time-efficiency.
The Aerolase Reverse™ protocol combines two independently ARTG-registered Class IIb medical devices — the Neo Elite (1064nm Nd:YAG) and the Era Elite (2940nm Er:YAG) — into a sequenced dual-modality approach. This allows practitioners to treat both dermal and epidermal structures in a streamlined, clinic-friendly session.
Notably, both devices are intended solely for use by licensed healthcare professionals or under their direct supervision, reflecting their status as clinical-grade tools designed for structured dermatological interventions.
As defined by the ARTG (ID 389750), the Aerolase Reverse™ system is approved for:
- Treatment of medical dermatological conditions, including acne, rosacea, onychomycosis and psoriasis
- Management of benign vascular and pigmented lesions
- Skin resurfacing and ablation of benign cutaneous lesions
- Skin tightening.
Why combine ND:YAG and ER:YAG?
The divide between treating the skin’s surface and its deeper structures has often required multiple tools or staggered appointments. Aerolase Reverse™ addresses this challenge through its dual-wavelength design.
The Neo Elite, delivering 650ms pulses of 1064nm Nd:YAG energy, is effective in targeting deeper vascular lesions and inflammatory conditions like acne, without excessive thermal build-up.
The Era Elite, using 300ms pulses of 2940nm Er:YAG energy, is designed for full-field epidermal ablation and precise skin resurfacing, with lower heat diffusion and minimal healing time compared with traditional ablative devices.
By combining both wavelengths in a single treatment plan, practitioners can address the full skin architecture — from superficial concerns to deeper inflammatory processes — while adhering to ARTG-listed purposes.
Designed for clinical flow, not hype
Aerolase Reverse™ is built to fit seamlessly into the real-world clinical environment. Rather than relying on subjective claims, its value proposition is rooted in clinical utility and protocol-based delivery.
Key features include:
- Dual-modality precision for layered dermatological applications
- Efficient session times, enabling same-day combination treatments
- Protocols designed with patient comfort in mind, minimising unnecessary tissue disruption
- Broad applicability across skin types (with protocols guided by clinical data).
There are no cosmetic or rejuvenation claims associated with Aerolase Reverse™’s ARTG listing, and marketing language is structured accordingly — making this device a strong fit for practices that prioritise ethical communication and compliance under TGA and Ahpra standards.
For clinics seeking a smart way to address complex skin presentations within the boundaries of medical regulation, Aerolase Reverse™ offers a compelling option. By combining dual-wavelength precision, clinical versatility and protocol integrity, this system empowers healthcare professionals to treat a range of ARTG-listed conditions confidently — without the need for multiple sessions or extensive recovery periods. AMP
The Aerolase Reverse™ approach was recently highlighted at the Non-Surgical Symposium by London-based aesthetic and plastic surgeon Dr Ali Ghanem.
‘Combining Er:YAG and Nd:YAG in sequence allows us to address superficial and deeper concerns in one procedure – without compromising safety or efficiency,’ says Dr Ghanem. ‘It opens up new options for evidence-based, personalised treatment planning.’
Backed by Beauty Technology
Distributed in Australia by Beauty Technology, Aerolase Reverse™ is part of a carefully curated suite of devices selected for their clinical evidence base, workflow efficiency and alignment with medical regulations. Rather than chasing trends, Beauty Technology focuses on tools that meet the practical and ethical needs of practitioners —from patient diversity to downtime minimisation.
Learn more about Aerolase Reverse™ and request clinical documentation at beautytechnology. com.au/aerolase/aerolase-reverse
